naftopidil has been researched along with pirarubicin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, H; Gotoh, A; Kino, Y; Kurioka, R; Mabuchi, M; Matsunaga, W; Nakao, S; Shimizu, T; Tanaka, A; Yamaguchi, K; Yamamoto, M | 1 |
1 other study(ies) available for naftopidil and pirarubicin
| Article | Year |
|---|---|
Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug.
Topics: Animals; Antineoplastic Agents; Female; Humans; Male; Mice; Naphthalenes; Piperazines; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2020 |